Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134805) titled 'A Clinical Study of Apatinib Mesylate Combined with Adebrelimab in Soft Tissue Sarcoma After First-Line Chemotherapy Failure' on Oct. 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)
Condition:
Soft tissue sarcoma who progressed after first-line chemotherapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Intervention group:32;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...